PRVB
Wells Fargo’s Provention Bio, Inc. Common Stock PRVB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2023
Q2 | – | Sell |
-56,101
| Closed | -$1.35M | – | 7412 |
|
|
2023
Q1 | $1.35M | Sell |
56,101
-3,747
| -6% | -$90.3K | ﹤0.01% | 2964 |
|
|
2022
Q4 | $633K | Buy |
59,848
+54,688
| +1,060% | +$578K | ﹤0.01% | 3293 |
|
|
2022
Q3 | $23K | Sell |
5,160
-367
| -7% | -$1.64K | ﹤0.01% | 5010 |
|
|
2022
Q2 | $22K | Sell |
5,527
-4,117
| -43% | -$16.4K | ﹤0.01% | 5128 |
|
|
2022
Q1 | $71K | Sell |
9,644
-20,656
| -68% | -$152K | ﹤0.01% | 5164 |
|
|
2021
Q4 | $170K | Buy |
30,300
+18,904
| +166% | +$106K | ﹤0.01% | 4983 |
|
|
2021
Q3 | $73K | Sell |
11,396
-13,687
| -55% | -$87.7K | ﹤0.01% | 5199 |
|
|
2021
Q2 | $212K | Sell |
25,083
-1,739
| -6% | -$14.7K | ﹤0.01% | 4713 |
|
|
2021
Q1 | $281K | Sell |
26,822
-26,186
| -49% | -$274K | ﹤0.01% | 4690 |
|
|
2020
Q4 | $898K | Buy |
53,008
+18,791
| +55% | +$318K | ﹤0.01% | 4040 |
|
|
2020
Q3 | $439K | Sell |
34,217
-12,041
| -26% | -$154K | ﹤0.01% | 4328 |
|
|
2020
Q2 | $652K | Buy |
46,258
+6,486
| +16% | +$91.4K | ﹤0.01% | 4028 |
|
|
2020
Q1 | $366K | Sell |
39,772
-13,185
| -25% | -$121K | ﹤0.01% | 4137 |
|
|
2019
Q4 | $788K | Buy |
52,957
+36,957
| +231% | +$550K | ﹤0.01% | 3949 |
|
|
2019
Q3 | $109K | Hold |
16,000
| – | – | ﹤0.01% | 5051 |
|
|
2019
Q2 | $194K | Buy |
+16,000
| New | +$194K | ﹤0.01% | 4808 |
|